Edgewise Therapeutics Inc. (EWTX)
44.06
+0.54 (1.24%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G Edgewise Therapeutics, Filed by: FMR LLC
August 6, 2026 10:20 AM - SEC Filing
Edgewise Therapeutics, Inc. (EWTX) Misses Q2 EPS by 6c
August 6, 2026 8:09 AM - StreetInsider
Form 10-Q Edgewise Therapeutics, For: Jun 30
August 6, 2026 8:06 AM - SEC Filing
Form 8-K Edgewise Therapeutics, For: Aug 06
August 6, 2026 8:06 AM - SEC Filing
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results
August 6, 2026 8:00 AM - PR NewsWire
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: ROOT JONATHAN D
July 17, 2026 4:25 PM - SEC Filing
Form 8-K/A Edgewise Therapeutics, For: Jul 10
July 16, 2026 8:01 AM - SEC Filing
Form 8-K Edgewise Therapeutics, For: Jul 10
July 13, 2026 8:37 AM - SEC Filing
Edgewise sells muscular dystrophy drug to Servier for up to $2.65B
July 13, 2026 8:30 AM - StreetInsider
Servier buys Edgewise muscular dystrophy unit for up to $2.65B
July 13, 2026 8:30 AM - StreetInsider
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
July 13, 2026 8:30 AM - PR NewsWire
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
July 13, 2026 8:30 AM - PR NewsWire
Oppenheimer Starts Edgewise Therapeutics (EWTX) at Outperform
July 9, 2026 6:01 AM - StreetInsider
Edgewise Therapeutics (EWTX) PT Raised to $51 at Guggenheim
July 6, 2026 8:17 AM - StreetInsider
Form 4 Edgewise Therapeutics, For: Jul 01 Filed by: Russell Alan J
July 2, 2026 5:21 PM - SEC Filing
Edgewise Therapeutics (EWTX) PT Raised to $51 at Guggenheim
July 2, 2026 12:48 PM - StreetInsider
Form 4 Edgewise Therapeutics, For: Jul 01 Filed by: Fox Jonathan C
July 1, 2026 7:46 PM - SEC Filing
Form 144 Edgewise Therapeutics, Filed by: Russell Alan J
July 1, 2026 4:55 PM - SEC Filing
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
July 1, 2026 8:00 AM - PR NewsWire
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: Brege Laura
June 17, 2026 5:14 PM - SEC Filing
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: Thompson Peter A.
June 17, 2026 4:50 PM - SEC Filing
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: Morris Arlene
June 17, 2026 4:47 PM - SEC Filing
Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'
June 17, 2026 6:47 AM - StreetInsider
Edgewise Therapeutics (EWTX) PT Raised to $32 at Goldman Sachs
June 17, 2026 5:30 AM - StreetInsider
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: Edris Badreddin
June 16, 2026 6:19 PM - SEC Filing
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: Martin Christopher Nathan
June 16, 2026 6:17 PM - SEC Filing
Form 4 Edgewise Therapeutics, For: Jun 05 Filed by: Fox Jonathan C
June 16, 2026 6:16 PM - SEC Filing
Edgewise Therapeutics (EWTX) PT Raised to $52 at Leerink
June 16, 2026 1:08 PM - StreetInsider
Biotech Bulls Stampede as Clinical Wins and Milestones Fuel Momentum
June 16, 2026 10:19 AM - StreetInsider
Truist Securities Reiterates Buy Rating on Edgewise Therapeutics (EWTX)
June 16, 2026 9:00 AM - StreetInsider
Leerink: 'CIRRUS Part D data continue to look supportive of EDG-7500’s potential'
June 16, 2026 8:55 AM - StreetInsider
SpaceX, Rackspace surge premarket; Edgewise Therapeutics, Huntsman fall
June 16, 2026 8:18 AM - StreetInsider
EDGEWISE reports Phase 2 HCM trial results for EDG-7500
June 16, 2026 7:00 AM - StreetInsider
Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
June 16, 2026 7:00 AM - PR NewsWire
Form 8-K Edgewise Therapeutics, For: Jun 04
June 5, 2026 4:33 PM - SEC Filing
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
June 3, 2026 4:01 PM - PR NewsWire
Edgewise Therapeutics (EWTX) PT Lowered to $48 at RBC Capital
June 2, 2026 7:16 AM - StreetInsider
Edgewise Therapeutics (EWTX) PT Raised to $66 at Raymond James
June 1, 2026 2:16 PM - StreetInsider
Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush
June 1, 2026 2:09 PM - StreetInsider
Form 8-K Edgewise Therapeutics, For: May 31
June 1, 2026 8:51 AM - SEC Filing
Edgewise Therapeutics sells sevasemten to Servier for up to $2.65 billion
June 1, 2026 8:31 AM - StreetInsider
Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
June 1, 2026 8:30 AM - PR NewsWire
Servier to acquire Edgewise muscular dystrophy business for $2.65 billion
June 1, 2026 8:30 AM - StreetInsider
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
June 1, 2026 8:30 AM - PR NewsWire
Form SCHEDULE 13G Edgewise Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 11:43 AM - SEC Filing
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026
May 12, 2026 8:00 AM - PR NewsWire
Full Article List
